Kwenzekeni
UMithrl, inkampani yengqalasizinda ye-AI ese-San Francisco, umemezele umzuliswano woxhaso wezigidi ezingama-20 we-Series A oholwa yi-Obvious Ventures, ngokubamba iqhaza kwe-Headline, AGI House, kanye nabaphathi abaningana bamakhemisi. Le nkampani, eyasungulwa ngo-2023 ngu-Vivek Adarsh kanye no-Shara Balakrishnan, ithuthukisa 'Injini Yezinqumo Zesayensi' (i-Mithrl-1) esebenza njengemodeli yomhlaba ye-biomedical. Ngokungafani namamodeli akhiqizayo adala ukulandelana kwamangqamuzana amasha, inkundla ye-Mithrl ikhipha ubudlelwano obuqinisekisiwe obusuka ezincwadini ezibuyekezwe ngontanga namadathasethi ozakwethu ukuze yazise izinqumo ze-R&D kulo lonke uchungechunge lokutholwa kwezidakamizwa. Uxhaso luzokweseka ukukhula kwethimba labo labantu abangama-30 kanye nokunwetshwa ezindaweni zokwelapha ezihlanganisa i-oncology, izifo ezihlobene nokuzivikela komzimba, kanye nesifo se-metabolic. UMithrl uphinde wamemezela ukuthi ukufinyelela kusenesikhathi endaweni yayo yesizukulwane sesibili kuzovulwa ngesonto elizayo.
UMithrl umemezele umzuliswano woxhaso wezigidi ezingama- $20 we-Series A oholwa yi-Obvious Ventures, ngokubamba iqhaza okwengeziwe okuvela ku-Headline, AGI House, kanye nabaphathi bekhemisi. Lokhu kulandela umzuliswano wembewu ka-$4 million oholwa yiBonfire Ventures ngoNovemba 2024. Le nkampani izinze eSan Francisco futhi yasungulwa ngo-2023 nguVivek Adarsh, owayengunjiniyela we-NVIDIA kanye ne-HP Labs, kanye noShara Balakrishnan.
Umkhiqizo oyinhloko wenkampani, u-Mithrl-1, uchazwa 'njengeNjini Yezinqumo Zesayensi' kunemodeli yesisekelo sebhayoloji. Ayikhiqizi ama-molecule amasha noma ukulandelana kwe-antibody kodwa kunalokho isebenzisa imodeli yomhlaba ye-biomedical ekhishwe ezincwadini ezibuyekezwe ngontanga kanye namasethi edatha asesidlangalaleni/ozakwethu. Le modeli ithwebula ubudlelwano obuqinisekisiwe phakathi kwezakhi zofuzo, izindlela, kanye nezifo ukwazisa izinqumo ze-R&D kusukela ekuhlonzeni okuqondisiwe kuya kumakholi wokuhumusha.
Inkundla isebenza njengehhanisi le-ejenti eliphatha umzila wemodeli, ukwenziwa ngcono kwamathokheni, kanye ne-orchestration yomongo. Kusatshalaliswa phambili ngaphakathi kwezindawo zamakhasimende, okubavumela ukuthi basebenzise amamodeli abo asemngceleni abawathandayo futhi banwebe inkundla ngedatha yokuphathelene. U-Mithrl uthi isistimu yakhe isebenzisa amathokheni ambalwa angu-45% kunokugeleza komsebenzi okujwayelekile futhi ifinyelela amaphuzu angu-0.96 ngokunemba kwesayensi kumabhentshimakhi akalwe ngochwepheshe, uma kuqhathaniswa no-0.60 ngaphandle kwenkundla.
Isisekelo sabasebenzisi be-Mithrl sihlanganisa izinkampani eziphezulu ze-pharma eziyi-10, ama-biotechs esiteji somtholampilo, kanye nozakwethu beplathifomu ye-genomics. Ukusebenzisana okuphawulekayo ne-Elephas Biosciences, okumenyezelwe ngo-Ephreli, kubhangqa iphrofayela yesikhathi sangempela yesimila se-ex vivo nokuhlaziywa okuqhutshwa yi-AI ukuze kutholakale izimpawu zokusabela kwe-immunotherapy. Le nkampani ithi okutholwe ngenkundla yayo kube nomthelela ekufakweni kwelungelo lobunikazi okungaphezu kwesigamu seshumi nambili.
Uxhaso olusha luzosetshenziselwa ukukhulisa ithimba lenkampani labantu ababalelwa ku-30 futhi kwandiswe ukugxila kwalo ezindaweni zokwelapha ezifana nesifo esihlobene nokuzivikela komzimba, i-oncology, isifo sikashukela, isifo se-metabolic kanye nesifo senhliziyo. U-Mithrl uphinde wamemezela ukuthi ukufinyelela kwangaphambi kwesikhathi kusiteji sayo sesizukulwane sesibili kuzovulwa ngesonto elizayo, nakuba amanani athile kanye nemininingwane yokutholakala okujwayelekile ayizange inikezwe emthonjeni.
Imininingwane yomthombo: en.wowtale.net ↗
Kungani kubalulekile
Lolu xhaso lugqamisa ukushintshwa kwe-biopharma eqhutshwa yi-AI isuka esizukulwaneni se-hypothesis iye ekuqinisekisweni kwe-hypothesis kanye ne-triage. Ngenkathi i-AI ingakwazi ukukhiqiza ngokushesha okuhlosiwe kwamakhandidethi, ibhodlela lihlala linquma ukuthi imiphi imibono ebambelele kumalebhu amanzi kanye nezilungiselelo zomtholampilo. Indlela yengqalasizinda kaMithrl, ehlanganisa namamodeli akhona emngceleni kanye nedatha yamakhasimende okuphathelene, ibhekana naleli gebe ngokunikeza izincomo eziqinisekisiwe, ezilandelwa ubufakazi. Le modeli inciphisa ubungozi bokulandela umkhondo ongavumelekile, okungenzeka kusheshiswe indlela esuka embonweni iye ekufayeleni kwe-IND. Ukutshalwa kwezimali kubonisa ukuzethemba kwabatshalizimali kungqalasizinda ye-AI ekhethekile, esekelwe kusizindalwazi ngaphezu kwama-ejenti esayensi anenjongo evamile.
Umkhakha wokutholwa kwezidakamizwa we-AI uhehe ngaphezu kwezigidigidi eziyi-11 zamarandi ngonyaka odlule, kodwa igebe elibalulekile lisasele phakathi kokukhiqiza imibono ecatshangelwayo nokuyiqinisekisa kumalebhu amanzi. Ingqalasizinda ye-Mithrl ibhekana nalokhu ngokunikeza ungqimba lwe-triage olufaka izizathu ngaphakathi kwebhayoloji eqinisekisiwe, ukunciphisa ingozi yokuphishekela imikhondo engavumelekile kanye namandla okusheshisa indlela esuka embonweni iye ekugcwaliseni kwe-IND.
Ngokuzimisa njengongqimba lwengqalasizinda esikhundleni sethuluzi lokuklama i-molecule, u-Mithrl uyazihlukanisa ezinkampanini ezifana ne-Xaira Therapeutics kanye ne-Isomorphic Labs. Indlela yayo ivumela amaqembu e-biopharma ukuthi agcine ukulawula idatha yawo kanye nezinketho zamamodeli, agweme ukukhiya abathengisi kuyilapho esebenzisa amandla amamodeli akhona asemngceleni.
Ukutshalwa kwezimali kubonisa inkambiso ebanzi ku-AI-for-biology ukuya kumasistimu akhethekile, asekelwe kusizinda ahlanganisa nokugeleza komsebenzi okukhona. Abatshalizimali abafana ne-Obvious Ventures bagcizelela ukuthi inzuzo ehlala isikhathi eside ilele kudatha yobunikazi, amamodeli omhlaba, nengqalasizinda yangokwezifiso eklanyelwe izidingo ezithile ze-biopharma, kunezixazululo ezilingana nosayizi owodwa.
Amamethrikhi okusebenza okufunwa u-Mithrl, okuhlanganisa ukufaneleka okuphezulu kwesayensi nokuncipha kokusetshenziswa kwamathokheni, aphakamisa izinzuzo ezingaba khona zamathimba e-R&D. Kodwa-ke, le miphumela isekelwe kumabhentshimakhi enkampani kanye nokuhlola okukalwe ngochwepheshe, futhi ukuqinisekiswa okuzimele kuzilungiselelo zomhlaba wangempela ezihlukene kusalindile.
I-Interactive Mechanism: Indlela Esebenza Ngayo Ngempela
Hlola ubuchwepheshe obuyisisekelo ngemuva kwalokhu kuthuthukiswa ngokuhlanganyela.
crm_get_transaction(id='4092').An agent must create a draft calendar event for Tuesday at 2 p.m. Which evidence would establish the requested result?
Ongakubuka ngokulandelayo
Gada ukukhishwa kwenkundla yesizukulwane sesibili sika-Mithrl kanye nohlelo lwayo lokufinyelela kwangaphambi kwesikhathi. Buka ubudlelwano obengeziwe nezinkampani eziphezulu eziyi-10 zamakhemisi kanye nama-biotechs esiteji somtholampilo. Landela ngomkhondo ukuthi izinzuzo ezifunwayo ezisebenza kahle, njengamathokheni ambalwa angu-45% kanye nezikolo zokunemba zesayensi eziphezulu, ziqinisekiswa ngokuzimela ekusetshenzisweni komhlaba wangempela. Qaphela ukuthi u-Mithrl uzihlukanisa kanjani nabaqhudelana nabo abafana no-Argon AI kanye nama-ejenti ocwaningo lwenhloso evamile endaweni eminyene ye-AI-for-biology.
Ukwethulwa kwenkundla yesizukulwane sesibili ye-Mithrl kanye nemigomo yohlelo lwayo lokufinyelela kusenesikhathi kuzoba izinkomba ezibalulekile zokulandelana kwezentengiselwano kanye nentuthuko yezobuchwepheshe. Imininingwane eqondile yamanani, izimo zokufinyelela, nezimfuneko zokuhlanganisa akwaziwa okwamanje.
Ukubambisana okuqhubekayo nezinkampani ezinkulu zekhemisi kanye nama-biotechs kuzokhombisa ukuqina nokwamukelwa kwesikhulumi ezindaweni eziphakeme ze-R&D. Ukunwetshwa ezindaweni ezintsha zokwelapha kuzohlola ukuguquguquka kwesikhulumi kanye nokujula kolwazi lwesizinda.
Ukuqinisekiswa okuzimele kwezimangalo zokusebenza kuka-Mithrl, okufana nokwehliswa kwamathokheni ngo-45% kanye nesikolo sokunemba kwesayensi esingu-0.96, kuzobaluleka ekutholeni ukwethembeka emphakathini wesayensi. Ukushicilelwa okubuyekezwe ontanga noma ukucwaninga kwenkampani yangaphandle kunganikeza lokhu kuqinisekisa.
Amandla okuncintisana nabanye abadlali bengqalasizinda ye-AI, njenge-Argon AI kanye nama-ejenti ocwaningo lwenhloso evamile, azobumba isimo semakethe. Amandla kaMithrl okugcina unqenqema ekunembeni okuqondile kwesizinda kanye nokuvumelana nezimo zokuhlanganisa kuzoba yisici esibalulekile empumelelweni yayo yesikhathi eside.